UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
XOMA LTD.
(Name of Issuer)
Common Shares, $.0005 par value
(Title of Class of Securities)
G9825R107
(CUSIP Number)
October 28, 1999
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
{ } Rule 13d-1(b)
{X} Rule 13d-1(c)
{ } Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 2 of 10 Pages
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Advantage Fund II Ltd.
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A){ }
(B){ }
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 3,400,174
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
3,400,174
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,400,174
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) { }
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- ------------------------------------------------------------------------- -
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 3 of 10 Pages
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Genesee International, Inc.
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A){ }
(B){ }
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 3,400,174
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
3,400,174
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,400,174
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) { }
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- ------------------------------------------------------------------------- -
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 4 of 10 Pages
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Donald R. Morken
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A){ }
(B){ }
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 3,400,174
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
3,400,174
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,400,174
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) { }
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9%
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- ------------------------------------------------------------------------- -
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 5 of 10 Pages
Item 1. Name and Address of Issuer:
XOMA Ltd.
2910 Seventh Street
Berkeley, California 94710
Item 2. (a) Names of Persons Filing:
Advantage Fund II Ltd. ("Advantage")
Genesee International, Inc. ("Genesee
International")
Donald R. Morken ("Mr. Morken")
(b) Address of Principal Business Office:
Advantage:
c/o CITCO
Kaya Flamboyan 9
Curacao, Netherlands Antilles
Genesee International:
CITCO Building
Wickhams Cay
P.O. Box 662
Road Town
Tortola, British Virgin Islands
Mr. Morken:
10500 N.E. 8th Street
Suite 1920
Bellevue, Washington 98004-4332
(c) Place of Organization or Citizenship:
Advantage: British Virgin Islands
Genesee International: Delaware
Mr. Morken: citizen of the United States
(d) Title of Class of Securities:
Common Shares, $.0005 par value
(e) CUSIP Number:
G9825R107
Item 3. This statement is filed pursuant to Rule 13d-1(c) by
Advantage, Genesee International and Mr. Morken.
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 6 of 10 Pages
Item 4. Ownership:
(a) Amount Beneficially Owned by Advantage, Genesee
International and Mr. Morken:
Advantage: 3,400,174
Genesee International: 3,400,174
Mr. Morken: 3,400,174
(b) Percent of Class:
Advantage: 5.9%
Genesee International: 5.9%
Mr. Morken: 5.9%
The Issuer reported that 55,552,763 Common Shares
were outstanding as of September 15, 1999 in its
Registration Statement on Form S-3 filed with the
Securities and Exchange Commission on September 16,
1999. Such amount was used to determine the
percentages of outstanding Common Shares reported in
this statement.
(c) Number of Shares as to which the Person has:
(i) sole power to vote or to direct
the vote
Advantage: -0-
Genesee International: -0-
Mr. Morken: -0-
(ii) shared power to vote or to
direct the vote
Advantage: 3,400,174
Genesee International: 3,400,174
Mr. Morken: 3,400,174
(iii) sole power to dispose or to
direct the disposition of
Advantage: -0-
Genesee International: -0-
Mr. Morken: -0-
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 7 of 10 Pages
(iv) shared power to dispose or to
direct the disposition of
Advantage: 3,400,174
Genesee International: 3,400,174
Mr. Morken: 3,400,174
The Common Shares listed as beneficially owned by the reporting persons
consist of shares owned directly by Advantage, shares issuable upon the
exercise of certain Common Share Purchase Warrants of the Issuer held by
Advantage, and shares which Advantage has the right to acquire pursuant to the
terms of a Subscription Agreement, dated as of January 28, 1999 (the
"Subscription Agreement"), by and between the Issuer and Advantage. The
number of Common Shares listed as beneficially owned herein is reported as of
the close of business on November 8, 1999. Based on circumstances occurring
after November 8, 1999, Advantage may be entitled to receive additional Common
Shares pursuant to the terms of the Subscription Agreement.
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable
Item 6. Ownership of More Than Five Percent on Behalf of Another
Person:
Not applicable
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on by the Parent
Holding Company:
Not applicable
Item 8. Identification and Classification of Members of the Group:
Not applicable
Item 9. Notice of Dissolution of Group:
Not applicable
Item 10. Certification:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the
effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in
connection with or as a participant in any transaction
having that purpose or effect.
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 8 of 10 Pages
Exhibits:
1. Joint Filing Agreement, dated as of November 8, 1999, by and among
Advantage, Genesee International and Mr. Morken.
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 9 of 10 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
ADVANTAGE FUND II LTD.
By: INTER CARIBBEAN
SERVICES LTD., Director
By: /s/ W.R. Weber
-----------------------
Name: W.R. Weber
Title: Attorney-in-fact
By: /s/ Declan Quilligan
-----------------------
Name: Declan Quilligan
Title: Assistant Secretary
Dated: November 8, 1999
GENESEE INTERNATIONAL, INC.
By: /s/ Donald R. Morken
-----------------------
Name: Donald R. Morken
Title: President
Dated: November 8, 1999
/s/ Donald R. Morken
-----------------------
Donald R. Morken
Dated: November 8, 1999
</PAGE>
SCHEDULE 13G
CUSIP No. G9825R107 Page 10 of 10 Pages
Exhibit 1
---------
JOINT FILING AGREEMENT
----------------------
This will confirm the agreement by and among the undersigned that
the Schedule 13G filed with the Securities and Exchange Commission on or about
the date hereof with respect to the beneficial ownership of the undersigned of
the Common Shares, $.0005 par value, of XOMA Ltd., a Bermuda company, is being
filed, and all amendments thereto will be filed, on behalf of each of the
persons and entities named below in accordance with Rule 13d-1(k) under the
Securities Exchange Act of 1934, as amended. This Agreement may be executed
in two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.
Dated: as of November 8, 1999
ADVANTAGE FUND II LTD.
By: INTER CARIBBEAN
SERVICES LTD., Director
By: /s/ W.R. Weber
-----------------------
Name: W.R. Weber
Title: Attorney-in-fact
By: /s/ Declan Quilligan
-----------------------
Name: Declan Quilligan
Title: Assistant Secretary
GENESEE INTERNATIONAL, INC.
By: /s/ Donald R. Morken
-----------------------
Name: Donald R. Morken
Title: President
/s/ Donald R. Morken
-----------------------
Donald R. Morken
|
